There are several ways to support the QiC Programme, and partners have the opportunity to help develop the programme alongside NHS and patient group experts.
QiC partners will benefit from exclusive networking opportunities with experts in the therapy area landscape over the lifecycle of each award programme.
"Sanofi is delighted to support the QIC Programme in 2022 and to recognise and reward the innovations that will benefit people living with diabetes. The QIC programme is at the forefront of sharing best practice to improve the quality of care, through demonstrating novel solutions to problems encountered by health care professionals and those impacted by diabetes on a daily basis. The commitment to quality of care is a core value of the NHS and the QIC programme is a shining example of that value in practice."
Debbie Woods, Head of Medical General Medicines UK and Ireland Sanofi